Concepedia

Lubomir Sokol

LS

Statistics

Publications

119

Citations

8.5K

H-Index

48

Active since

1994

Affiliations

Moffitt Cancer Center(Current)

University of South Florida

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Fred Hutch Cancer Center

Lubomir Sokol is an author at Moffitt Cancer Center specializing in medicine, pathology, and hematology.

ORCID

Top concepts

Publications per year

1994–2023

119

Publications

119

Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy

Bertrand Coiffier, Barbara Pro, H. Miles Prince et al. · Journal of Clinical Oncology · 2012 · 664 citations

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 569 citations

, , +9

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

Ashley A. Basiorka, Kathy L. McGraw, Erika A. Eksioglu et al. · Blood · 2016 · 337 citations · Full text

Non-Hodgkin’s Lymphomas

Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani et al. · Journal of the National Comprehensive Cancer Network · 2010 · 328 citations · Full text

Siltuximab, a Novel Anti–Interleukin-6 Monoclonal Antibody, for Castleman's Disease

Frits van Rhee, Luis Fayad, Peter M. Voorhees et al. · Journal of Clinical Oncology · 2010 · 240 citations

1–5 of 119